During the past decade, Philadelphia CyberKnife conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Philadelphia CyberKnife" #1 collaborator was "Community Medical Center, Toms River, NJ" with 1 trials as a collaborator, "Saint Peters University Hospital" with 1 trials as a collaborator and "VisionTree" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Philadelphia CyberKnife" are "Arteriovenous Malformation of Central Nervous System" (1 trials), "Metastatic Nonsmall Cell Lung Cancer" (1 trials), "Neoplasms" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Trigeminal Neuralgia" (1 trials). Many other conditions were trialed in "Philadelphia CyberKnife" in a lesser frequency.

Most popular intervention types in "Philadelphia CyberKnife" are "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "SRS/SBRT" (1 trials) and "Stereotactic Body Radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Philadelphia CyberKnife" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Philadelphia CyberKnife". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Philadelphia CyberKnife, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Philadelphia CyberKnife, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".